Navigation Links
A hands-on approach to treating patients with pulmonary disease
Date:8/14/2012

EAST LANSING, Mich. Researchers at Michigan State University are working to show how a noninvasive, drug-free form of hands-on medical care can help patients with chronic obstructive pulmonary disease improve their breathing.

The team from MSU's College of Osteopathic Medicine will apply four osteopathic manipulative treatments to a group of patients with moderate to severe chronic obstructive pulmonary disease. One of the most common lung diseases, COPD typically manifests as chronic bronchitis (a long-term cough with mucus) or emphysema (destruction of the lungs over time).

The goal, said lead researcher and associate professor Sherman Gorbis, is to attempt to determine the biochemical changes in patients' blood following osteopathic manipulation, a treatment where a physician uses his or her hands to diagnose and treat patients.

Osteopathic manipulative treatments have been used throughout the United States since the late 1800s. The techniques can be used to alleviate pain, restore range of motion and enhance the immune system.

However, Gorbis said, much of the evidence of the treatments' success has been anecdotal.

"That's what makes this project exciting," Gorbis said. "This will be one of the first studies to attempt to correlate treatment to pulmonary function and biochemical markers.

"If we can demonstrate that certain biochemical markers are enhanced with osteopathic manipulative treatment and show patients have increased pulmonary function, this could become a powerful teaching tool."

The study is being paid for with a nearly $100,000, two-year grant from the American Osteopathic Association in partnership with the Osteopathic Heritage Foundation.

The research team will recruit patients who have enrolled in McLaren-Greater Lansing Hospital's pulmonary rehabilitation program. As part of the trial, one group will undergo the osteopathic treatments, a second group will undergo a "sham treatment" that is hands-on but does not include manipulation and a third group will receive only the protocol normally part of the rehabilitation program with no hands-on treatment.

As patients join the trial, which will last 12 weeks for each enrollee, they will have blood drawn every two weeks. Those draws will be analyzed and measured. About 60 patients will take part over the two-year trial.

"By learning if certain biomarkers in the blood and plasma are enhanced in the group receiving the manipulation treatment, we hope to identify the physiological changes occurring among the patients," said Gorbis, who noted patients also will undergo exercise tolerance tests and complete questionnaires during the trial.

"While medication helps, there is no cure for COPD. But if we can improve the breathing process, and show how we are doing it, we can improve the quality of life of these patients."

Gorbis is working on the project with fellow osteopathic physicians Donald Sefcik, William Pintal and Aaron Bohrer, as well as fourth-year osteopathic medical student Kerry Melenovsky. Biochemists John Wang and Daniel Jones also are on the research team.

A successful pilot project will allow the team to seek funding from the National Institutes of Health to recruit larger numbers of patients in a multi-center trial.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Related medicine news :

1. UH students spent summer making a difference with hands-on research
2. GWU consensus report outlines new approaches for evaluating benefits and risks of obesity drugs
3. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
4. MDC researchers develop new approach to treat acute liver failure
5. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
6. Study implements community-based approach to treat HIV-infection in rural Uganda
7. Expert panel calls for new research approach to prevent youth violence
8. First-of-its-kind approach nanomedicine design effectively targets cancer with decreased toxicity
9. Researchers offer new approach to track former prisoners access to community HIV care
10. A better way to test new treatments? Approach could help patients and give useful results
11. Success of fertility treatment may approach natural birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A hands-on approach to treating patients with pulmonary disease
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: